59 related articles for article (PubMed ID: 1504017)
1. Inducible transformation of cells from transgenic mice expressing SV40 under lac operon control.
Epstein-Baak R; Lin Y; Bradshaw V; Cohn M
Cell Growth Differ; 1992 Feb; 3(2):127-34. PubMed ID: 1504017
[TBL] [Abstract][Full Text] [Related]
2. Parameters affecting the use of the lac repressor system in eukaryotic cells and transgenic animals.
Wyborski DL; DuCoeur LC; Short JM
Environ Mol Mutagen; 1996; 28(4):447-58. PubMed ID: 8991077
[TBL] [Abstract][Full Text] [Related]
3. Retroviral infection of primary hepatocytes from normal mice and mice transgenic for SV40 large T antigen.
Weber-Benarous A; Decaux JF; Bennoun M; Allemand I; Briand P; Kahn A
Exp Cell Res; 1993 Mar; 205(1):91-100. PubMed ID: 7681009
[TBL] [Abstract][Full Text] [Related]
4. Control of Ha-ras-mediated mammalian cell transformation by Escherichia coli regulatory elements.
Liu HS; Scrable H; Villaret DB; Lieberman MA; Stambrook PJ
Cancer Res; 1992 Feb; 52(4):983-9. PubMed ID: 1737361
[TBL] [Abstract][Full Text] [Related]
5. Hyperplasia in multiple smooth muscle tissues in transgenic mice expressing a temperature-sensitive SV40 T-antigen under the control of smooth muscle alpha-actin regulatory sequences.
March KL; Sandusky G; Fan L
Oncogene; 1999 Jun; 18(25):3773-82. PubMed ID: 10391686
[TBL] [Abstract][Full Text] [Related]
6. Expression in transgenic mice of the large T antigen of polyomavirus induces Sertoli cell tumours and allows the establishment of differentiated cell lines.
Paquis-Flucklinger V; Michiels JF; Vidal F; Alquier C; Pointis G; Bourdon V; Cuzin F; Rassoulzadegan M
Oncogene; 1993 Aug; 8(8):2087-94. PubMed ID: 8393161
[TBL] [Abstract][Full Text] [Related]
7. Breaking immunologic ignorance to an antigenic peptide of simian virus 40 large T antigen.
Soldevila G; Geiger T; Flavell RA
J Immunol; 1995 Dec; 155(12):5590-600. PubMed ID: 7499842
[TBL] [Abstract][Full Text] [Related]
8. Transformation of astrocytes in transgenic mice expressing SV40 T antigen under the transcriptional control of the glial fibrillary acidic protein promoter.
Danks RA; Orian JM; Gonzales MF; Tan SS; Alexander B; Mikoshiba K; Kaye AH
Cancer Res; 1995 Oct; 55(19):4302-10. PubMed ID: 7671240
[TBL] [Abstract][Full Text] [Related]
9. Escherichia coli lac repressor-lac operator interaction and the influence of allosteric effectors.
Horton N; Lewis M; Lu P
J Mol Biol; 1997 Jan; 265(1):1-7. PubMed ID: 8995519
[TBL] [Abstract][Full Text] [Related]
10. Differentiation versus proliferation of transgenic mouse lens cells expressing polyoma large T antigen: evidence for regulation by an endogenous growth factor.
Griep AE; Westphal H
New Biol; 1990 Aug; 2(8):727-38. PubMed ID: 2178003
[TBL] [Abstract][Full Text] [Related]
11. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene.
Sepulveda AR; Finegold MJ; Smith B; Slagle BL; DeMayo JL; Shen RF; Woo SL; Butel JS
Cancer Res; 1989 Nov; 49(21):6108-17. PubMed ID: 2551499
[TBL] [Abstract][Full Text] [Related]
12. Differentiation is induced in three-dimensional cultures of brain cells immortalized by the LAP mammalian regulatory system.
Toth M; Shenk T; Madarasz E
J Neurosci Res; 1995 Aug; 41(6):764-74. PubMed ID: 7500378
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of neonatal mouse sertoli cell lines.
Hofmann MC; Van Der Wee KS; Dargart JL; Dirami G; Dettin L; Dym M
J Androl; 2003; 24(1):120-30. PubMed ID: 12514093
[TBL] [Abstract][Full Text] [Related]
14. A transgenic mouse model for lung adenocarcinoma.
Sandmöller A; Halter R; Suske G; Paul D; Beato M
Cell Growth Differ; 1995 Jan; 6(1):97-103. PubMed ID: 7718490
[TBL] [Abstract][Full Text] [Related]
15. Transgenic mice bearing the polyomavirus large T antigen directed by 2.1 kb of the keratin 19 promoter develop bronchiolar papillary tumors with progression to lung adenocarcinomas.
Lebel M; Webster M; Muller WJ; Royal A; Gauthier J; Mes-Masson AM
Cell Growth Differ; 1995 Dec; 6(12):1591-600. PubMed ID: 9019164
[TBL] [Abstract][Full Text] [Related]
16. Thymic epithelial neoplasms in transgenic mice expressing SV40 T antigen under the control of an erythroid-specific enhancer.
Teitz T; Chang JC; Kan YW; Yen TS
J Pathol; 1995 Nov; 177(3):309-15. PubMed ID: 8551394
[TBL] [Abstract][Full Text] [Related]
17. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors.
Tzeng YJ; Zimmermann C; Guhl E; Berg B; Avantaggiati ML; Graessmann A
Oncogene; 1998 Apr; 16(16):2103-14. PubMed ID: 9572491
[TBL] [Abstract][Full Text] [Related]
18. Cell-based delivery of cytokines allows for the differentiation of a doxycycline inducible oligodendrocyte precursor cell line in vitro.
Muth H; Elmshauser C; Broad S; Schipke C; Kettenmann H; Beck E; Kann M; Motta I; Chen U
J Gene Med; 2001; 3(6):585-98. PubMed ID: 11778905
[TBL] [Abstract][Full Text] [Related]
19. Cyclin-dependent kinase inhibitor expression in pulmonary Clara cells transformed with SV40 large T antigen in transgenic mice.
Magdaleno SM; Wang G; Mireles VL; Ray MK; Finegold MJ; DeMayo FJ
Cell Growth Differ; 1997 Feb; 8(2):145-55. PubMed ID: 9040936
[TBL] [Abstract][Full Text] [Related]
20. Pituitary neoplasia induced by expression of human neurotropic polyomavirus, JCV, early genome in transgenic mice.
Gordon J; Del Valle L; Otte J; Khalili K
Oncogene; 2000 Oct; 19(42):4840-6. PubMed ID: 11039901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
